Invention Grant
- Patent Title: Mutated organophosphorus acid anhydrolases and their uses thereof
- Patent Title (中): 突变的有机磷酸酐水解酶及其用途
-
Application No.: US14946276Application Date: 2015-11-19
-
Publication No.: US09587232B1Publication Date: 2017-03-07
- Inventor: Steven P. Harvey , Mark A. Guelta
- Applicant: U.S. Army Edgewood Chemical and Biological Command
- Applicant Address: US DC Washington
- Assignee: The United States of America as Represented by the Secretary of the Army
- Current Assignee: The United States of America as Represented by the Secretary of the Army
- Current Assignee Address: US DC Washington
- Agent Ulysses John Biffoni
- Main IPC: D06M16/00
- IPC: D06M16/00 ; C02F3/34 ; B09C1/10 ; C12N9/14 ; C12P21/06 ; C12P19/34 ; C07H21/04 ; C07K1/00 ; A62D3/34 ; C12N9/16 ; A61K38/46
Abstract:
The invention is directed toward non-wild-type organophosphorus acid anhydrolases having three site mutations, method of production, and method of use to effectively degrade toxic chemicals such as N,N-diethyl-2-(methyl-(2-methylpropoxy)phosphoryl)sulfanylethanamine) (“VR”).
Information query
